FA(S)CE TO FACE – MEET OUR EXPERTS

29/06/2020

This time you will have a chance again to meet our Field Application Scientist Team members and get to know who you are facing on a special Omixon training. Let’s see who they are: Renata Santos, CHT (ABHI) – Senior FAS, the Americas Oi! My name is Renata and I...

Interview with Prof. Milena Ivanova MD, Molecular Biologist from the University Hospital Aleksandrovska

26/06/2020

The following interview is part of our interview series that we are conducting with Key Opinion Leaders, Experts and Business Managers within the HLA field. In this interview, Prof. Milena Ivanova MD, Molecular Biologist from the University Hospital Aleksandrovska talks about their experiences and thoughts on HLA laboratory activities....

HLA EXPLORE™ can help you in your COVID research and Omixon offers 50% off the annual licence fee for Research Institutions until the end of 2020

28/05/2020

HLA Explore NGS software can analyze any experiment type – targeted exons, targeted whole genes, whole MHC, whole transcriptome, whole exome or whole genome – of your patient’s NGS samples. While recovering from the COVID crises Omixon offers 50% off the annual licence fee for Research Institutions until the...

Behind The Sc(re)enes

27/05/2020

This time you will have a chance to meet our Technical Support Team members and get to know who is sitting behind the sc(re)enes at Omixon answering your email inquiries and questions at all times of the day and night. Let’s see who they are: TJ: “Hi Everyone, my...

Do We Outsmart the Virus or Does the Virus Outsmart Us?

26/05/2020

Written by Nina Lauterbach (FAS, Omixon) About 3,500 years ago, a scholar in Egypt started writing in the oldest medical text known in history. One of the diseases he described was something called Resh. The name is weird and unfamiliar, but the symptoms might ring a bell, a cough...